| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.4M | -35.5% |
| SG&A Expense | $8.3M | +55.5% |
| Operating Income | -$12.3M | +27.3% |
| Interest Expense | $9K | +25.5% |
| Pre-tax Income | -$13.7M | +18.0% |
| Income Tax | -$113K | +62.9% |
| Net Income | -$13.6M | +17.1% |
| EPS (Basic) | -$18.55 | -948.0% |
| EPS (Diluted) | -$18.55 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.0M | -24.1% |
| Current Assets | $7.7M | -14.6% |
| Total Assets | $18.7M | +3.4% |
| Current Liabilities | $3.3M | +103.3% |
| Total Liabilities | $7.3M | -17.7% |
| Stockholders' Equity | $11.4M | +23.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.4M | +4.2% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $6K | +104.1% |
| Financing Cash Flow | $8.6M | -51.6% |
| Free Cash Flow | -$10.4M | +4.8% |
| -948.0% |